[Indications of antihypertensive treatment in non-malignant hypertension].
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001014:Aortic Aneurysm / Q000209:etiology; D001581:Benzothiadiazines; D002561:Cerebrovascular Disorders / Q000209:etiology; D003327:Coronary Disease / Q000209:etiology; D004232:Diuretics; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D007674:Kidney Diseases / Q000209:etiology; D011379:Prognosis; D012110:Reserpine / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D006830:Hydralazine; D012110:Reserpine
Les indications d'un traitement antihypertensif dans l'hypertension non maligne